Petitioner: Duplex Consensus Sequencing Method Not Patentable

(May 10, 2022, 12:21 PM EDT) -- ALEXANDRIA, Va. — In a May 6 petition for inter partes review (IPR) filed with the Patent Trial and Appeal Board, an oncology technology company requests cancellation of a duplex consensus...

To view the full article, register now.